$AME

AME: AMETEK Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

AMETEK Inc. reported Q3 sales of $2.22B, up 17%, with adjusted EPS of $2.21, also up 17%. The company raised FY26 adjusted EPS guidance to $8.53-$8.57 from $8.20-$8.30. The stock has shown varied reactions to past news, with a median move of 1.0% in either direction.

Original reporting
Published Nov 3, 2026, 3:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 4:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AME
Bullish
medium confidence
Mentioned
$AME
Relevance
7/10
AlphAI data visualization · based on quantisnow.com
Decision brief

The 30-second read

$AMEBullishMed
01

Why it matters

Raised FY26 adj EPS guidance to $8.53-$8.57 from $8.20-$8.30 is the key decision-relevant datapoint, alongside Q3 record sales and adj EPS growth.

02

Market read

Traders can update valuation and positioning based on the guidance raise and the reported Q3 growth figures.

03

What to watch

Without segment margins, cash flow, or order backlog details, traders may discount the quality of earnings and focus on whether the guidance raise is sustainable.

Relevance 7/10Novelty 6/10Timing: 8-K filing reported today, after-hours/next-session positioning

Background

The article states AMETEK filed an SEC Form 8-K covering Q3 results and financial condition, including raised FY26 adj EPS guidance.

Company-level read

Ticker impact

$AMEBullishMedium confidence
Context

Ametek filed an 8-K with Q3 record sales of $2.22B (+17%) and raised FY26 adj EPS guidance to $8.53-$8.57.

Expected impact

Likely upward bias as traders price in higher FY26 adj EPS guidance.

Evidence & confidence

The article attributes both a quarterly beat (sales and adj EPS up 17%) and a specific FY26 guidance increase, which are direct earnings drivers.

Market effects

Supports sentiment for industrial machinery/components names by reinforcing demand and earnings momentum.

Limited, company-specific read-through to US industrials.

Low, no cross-border policy or macro linkage described.

Counterpoint

The piece may be largely a filing/recap wrapper, and the market may already have priced the guidance change from earlier coverage.

Key entities

  • AMETEK Inc.

    Subject company filing an 8-K with Q3 results and raised FY26 adj EPS guidance.

Related articles

$AMEHighAI 9/10

AMETEK Posts Record Q3 Sales and Adjusted EPS, Raises 2026 Guidance

AMETEK reported Q3 2026 sales of $2.22B, up 17% YoY, and adjusted EPS of $2.21. GAAP EPS was $1.85, with net income at $426.3M. The company raised its full-year adjusted EPS outlook to $8.53–$8.57. Growth was driven by organic sales, acquisitions, and strong demand across its businesses. AMETEK also completed the acquisition of Indicor Instrumentation.

$AMEHighAI 9/10

AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Nov 3, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the third quarter ended September 30, 2026. AMETEK’s third quarter 2026 sales were a record

$AMEMedAI 8/10

AMETEK Boosts FY26 Outlook - Update

AMETEK (AME) reported Q3 results and raised its FY26 outlook. Q4 adjusted earnings are expected to be $2.26-$2.30 per share with net sales growth in the low 20% range. FY26 adjusted earnings are now projected to be $8.53-$8.57 per share with mid-teen percentage net sales growth, up from previous guidance of $8.20-$8.30 per share. AME stock is up 0.86% in pre-market trading.

$AMEMedAI 9/10

AMETEK’s (NYSE:AME) Q3 2026 sales beat estimates

AMETEK reported Q3 2026 revenue of $2.22 billion, exceeding estimates by 2.9% and growing 17.3% year-on-year. Adjusted EPS was $2.21, beating estimates by 4.8%. Management raised full-year adjusted EPS guidance to $8.55 at the midpoint, a 3.6% increase. Operating margin remained steady at 26.3%, while free cash flow margin improved to 23.8% from 22.2% year-on-year.

$AMEMedAI 9/10

Ametek: Q3 Earnings Snapshot

Ametek Inc. (AME) reported Q3 net income of $426.3M, or $1.85 per share, beating estimates. Revenue was $2.22B, also surpassing forecasts. The company projects Q4 EPS of $2.26-$2.30 and full-year EPS of $8.53-$8.57. Shares are up 18% YTD and 20% over 12 months.